Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease - Concepedia

Concepedia

Publication | Open Access

Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease

DOI Full Paper Access

95

Citations

40

References

2014

Year

Jacob A. Udell, David A. Morrow, Petr Jarolı́m, Sarah Sloan, Elaine Hoffman, Thomas F.X. O’Donnell, Amit N. Vora, Torbjørn Omland, Scott D. Solomon, Marc A. Pfeffer,

Journal of the American College of Cardiology

Cardiovascular PrognosisFibrosisAngiogenesisCardiovascular DiseaseEndothelial DysfunctionPathologyFibroblast Growth Factor-23Fibroblast Growth FactorCardiologyVascular BiologyMedicineAtherosclerosisAngiotensin-converting Enzyme Inhibition

References

	Year	Citations

Page 1

Page 1